The S&P 500 added 1% on Friday, June 6, as a strong jobs report pointed to resilience in the labor market despite ...

Meanwhile, Moderna has progressed nicely on its cost cutting program, and beyond this year, plans to reduce as much as $1.7 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

Walt Disney is laying off several hundred people globally across multiple divisions, including marketing for film and television, TV publicity, casting and development, and corporate financial ...

Moderna's (MRNA) new COVID vaccine approval targets a broader high-risk population. Check out why I see potential for a 25-40 ...

Moderna, Inc. (NASDAQ:MRNA) shares are trading higher Monday after the company announced its new COVID-19 vaccine secured ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries reached last ...

Tesla (TSLA) sales were mixed in Europe during May. Its sales in Norway more than tripled, while sales in France, Sweden, ...